LINC02128: A Potential Drug Target and Biomarker (G102724940)

Target Name: LINC02128

NCBI ID: G102724940

LINC02128

Other Name(s): Long intergenic non-protein coding RNA 2128 | LINC02187 | long intergenic non-protein coding RNA 2128

LINC02128: A Potential Drug Target and Biomarker

LINC02128 is a non-protein coding RNA (ncRNA) that has been identified in various studies as having potential drug targets and biomarkers. This RNA is highly expressed in various tissues and has been associated with various diseases, including cancer. Therefore, it is of great interest to investigate the potential drug targets and biomarkers of LINC02128.

Drug Targets

LINC02128 has been predicted to have several potential drug targets. One of the predicted targets is the protein encoded by the LINC02128 gene, which is known as LIMD1. LIMD1 is a nuclear protein that is involved in various cellular processes, including cell adhesion, migration, and invasion. It is also known to play a role in the development and progression of cancer. Therefore, targeting LIMD1 with small molecules or antibodies that can inhibit its functions could be a potential drug for cancer treatment.

Another predicted target of LINC02128 is the microRNA (miRNA) pathway. miRNA is a small non-coding RNA that plays a critical role in post-transcriptional gene regulation. It can target specific mRNAs for degradation by the 26S ribosome, and it is also involved in the regulation of cellular processes, including cell growth, apoptosis, and inflammation. Therefore, targeting miRNA pathways with small molecules or antibodies that can inhibit miRNA function could be a potential drug for various diseases, including cancer.

Biomarkers

LINC02128 has also been predicted to be a potential biomarker for various diseases, including cancer. One of the predicted biomarkers is the expression of LINC02128, which can be used as a marker for cancer diagnosis or monitoring. Another predicted biomarker of LINC02128 is its expression level, which can be used as a marker for cancer treatment response.

Another potential biomarker of LINC02128 is its expression level in various tissues, including cancer cells, normal cells, and various organs. Cancer cells are known to have altered expression of various genes, including LINC02128. Therefore, measuring the expression level of LINC02128 in cancer cells and comparing it to the expression level in normal cells or organs could be a potential biomarker for cancer diagnosis or monitoring.

Conclusion

In conclusion, LINC02128 is a non-protein coding RNA that has potential as a drug target and biomarker. Its predicted drug targets include the protein encoded by the LINC02128 gene (LIMD1) and the miRNA pathway. Its predicted biomarkers include its expression level, which can be used as a marker for cancer diagnosis or monitoring, and its expression level in various tissues, including cancer cells, normal cells, and various organs. Further research is needed to confirm the potential drug targets and biomarkers of LINC02128.

Protein Name: Long Intergenic Non-protein Coding RNA 2128

The "LINC02128 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC02128 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets